Page 1 of Clinical Trials for Drug Capecitabine plus oxaliplatin, 65 Total Matches
- 1RecruitingLast Updated: November 9, 2011Condition(s): Gastric Cancer
- 2RecruitingLast Updated: March 2, 2012Condition(s): Gastric Cancer
- 3CompletedLast Updated: October 27, 2010Condition(s): Metastatic Colorectal Cancer
- 4CompletedLast Updated: April 8, 2010Condition(s): Metastatic Colorectal Cancer
- 5RecruitingLast Updated: December 19, 2009Condition(s): Colorectal Cancer
- 6Active, not recruitingLast Updated: March 16, 2012Condition(s): Gastric Adenocarcinoma
- 7Active, not recruitingLast Updated: February 3, 2012Condition(s): Colorectal Cancer
- 8Not yet recruitingLast Updated: October 18, 2009Condition(s): Potentially Resectable Liver Metastasis From CRC; Colorectal Cancer
- 9RecruitingLast Updated: April 7, 2011Condition(s): Gastric Cancer
- 10Active, not recruitingLast Updated: May 17, 2012Condition(s): or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.; ErbB2 (HER2) Amplified Gastric; Neoplasms, Gastrointestinal Tract; Esophageal
- 11Active, not recruitingLast Updated: November 11, 2011Condition(s): Colorectal Neoplasms
- 12RecruitingLast Updated: February 7, 2012Condition(s): Cognitive/Functional Effects; Colorectal Cancer; Neurotoxicity
- 13RecruitingLast Updated: September 7, 2010Condition(s): Colorectal Cancer
- 14TerminatedLast Updated: November 23, 2009Condition(s): Colorectal Cancer
- 15RecruitingLast Updated: April 17, 2012Condition(s): Subjects With Advanced Solid Tumors (Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer).
- 16CompletedLast Updated: July 5, 2011Condition(s): Colorectal Cancer
- 17CompletedLast Updated: August 23, 2011Condition(s): Metastatic Colorectal Cancer
- 18RecruitingLast Updated: September 17, 2009Condition(s): Advanced Colorectal Cancer
- 19Active, not recruitingLast Updated: April 16, 2012Condition(s): Metastatic Breast Cancer
- 20RecruitingLast Updated: January 17, 2012Condition(s): Colorectal Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Capecitabine+plus+oxaliplatin
